$Orgenesis (ORGS.US)$ Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. On October 17, 2024, the Nasdaq Stock Market LLC (“Nasdaq”) notified Orgenesis Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s securities will be suspended at the open of trading on October 21, 2024.
Arrayfunction
:
Would you mind explaining how to incorporate float volume when evaluating a stock? That's one topic I haven't come across in any formal learning material. I know that it refers to the number of shares available for trading. I mostly haven't figured out if it can be used in the absence of confirmation bias with all the possible branches like..... Low float -> low liquidity -> higher risk -> removes low-risk investors (obligated like fiduciaries or individual people) -> reduced demand increases volatility -> consumer base further limited -> company becomes undesirable preventing natural share value growth -> share price extremely sensitive to any trading -> outcome ultimately up to market makers vs short sellers -> technical and fundamental analysis become irrelevant -> swing trading is reduced to a game of roulette where you bet on either the market makers or short sellers. Did I get the standard line of thought correct?
Arrayfunction
Stock_Drift
OP
:
Thank you! I hadn't mentally spelled it out until writing my question. The way people behave around low float penny stocks suddenly makes a lot more sense!
Jaguar8
OPWorldShowMe
:
There is a possibility since they are cash strapped. However, my guess is they wont immediately offer because they have to maintain 1 dollar per share for straight 10 Days to comply with listing requirements. By diluting, they run the risk of dragging it back again to below 1 dollar. Just be cautious and secure profits at once
$Orgenesis (ORGS.US)$Reuters· 1 min ago Orgenesis Inc: Data Indicate a Potentially Favorable Safety Profile With a Lower Incidence of Cytokine Release Syndrome
Report
No comment yet
Sign in to post a comment
Market Insights
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Orgenesis Stock Forum
what's going on here..?
Orgenesis: Nasdaq to Delist Co 's Common Stock, Securities Trading Will Be Suspended on Oct 21
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.
On October 17, 2024, the Nasdaq Stock Market LLC (“Nasdaq”) notified Orgenesis Inc. (the “Company”) that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s securities will be suspended at the open of trading on October 21, 2024.
$CN Energy (CNEY.US)$ $Taoping (TAOP.US)$ $Alset (AEI.US)$ $Ambipar Emergency Response (AMBI.US)$ $Knightscope (KSCP.US)$ $Orgenesis (ORGS.US)$ $ShiftPixy(Delisted) (PIXY.US)$ $Aurora Mobile (JG.US)$ $CN Energy (CNEY.US)$
📊⚡️📊
Orgenesis Inc: Data Indicate a Potentially Favorable Safety Profile With a Lower Incidence of Cytokine Release Syndrome
No comment yet